IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on July 29, 2016. The filing serves to announce the Company's financial results for the second quarter ended June 30, 2016. The report references a press release furnished as Exhibit 99.1 containing the detailed results.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) but are not included in the body of this Form 8-K document.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that results for the second quarter ended June 30, 2016, have been issued.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. The document explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 29, 2016) for actual revenue, net income, and earnings per share figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any forward-looking statements or guidance updates in the press release not captured in this summary.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full financial release.